MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TSHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Taysha Gene Therapies (TSHA) Ownership - Who owns Taysha Gene Therapies?

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
99
Web
https://www.tayshagtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.64B
P/E Ratio
2.70
Total Cash
455.41M
Projected Growth
N/A
Total Debt
56.71M
Revenue
5.49M
Risk (Beta)
3.32
Dividend Yield
N/A
Total Cash/Share
1.40
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
TSHA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for TSHA
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
3000 Pegasus Park Drive
Phone
+1 214 612-0000
Employees
99
Web
https://www.tayshagtx.com
Who owns Taysha Gene Therapies? TSHA symbol Ownership - Tickeron.com